All Resources

This page provides filters and search facilities across all types of CF resources contained within the ECFS website.

Additionally, you can visit the specific resource type pages as follows:

More information on CF publications can be found here: Publications

November 2016

Title: Oxidized glutathione and uric acid as biomarkers of early cystic fibrosis lung disease
References
J Cyst Fibros. 2016 Nov 24. pii: S1569-1993(16)30647-6

November 2016

Title: Continuous alternating inhaled antibiotic therapy in CF: a single center retrospective analysis.
References
J Cyst Fibros. 2016 Nov;15(6):802-808.
Title: Biomarkers for Cystic Fibrosis Drug Development
References
 2016 Nov;15(6):714-723
Title: Continuous alternating inhaled antibiotic therapy in CF: a single center retrospective analysis.
References
J Cyst Fibros. 2016 Nov;15(6):802-808.

November 2016

Title: Bacterial proteases and haemostasis dysregulation in the CF lung.
References
J Cyst Fibros. 2016 Nov 10.
Title: Bacterial proteases and haemostasis dysregulation in the CF lung.
References
J Cyst Fibros. 2016 Nov 10.

November 2016

Title: Multilocus amplicon sequencing of Pseudomonas aeruginosa cystic fibrosis airways isolates collected prior to and after early antipseudomonal chemotherapy
References
J Cyst Fibros. 2016 Nov 8. pii: S1569-1993(16)30648-8
Title: Multilocus amplicon sequencing of Pseudomonas aeruginosa cystic fibrosis airways isolates collected prior to and after early antipseudomonal chemotherapy
References
J Cyst Fibros. 2016 Nov 8. pii: S1569-1993(16)30648-8

November 2016

Title: Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis
References
Regan KH, Bhatt J. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2016, Issue 11. Art. No.: CD009876. DOI: 10.1002/14651858.CD009876.pub3
Theme
Lung Disease and Infection
Title: Biomarkers for Cystic Fibrosis Drug Development
References

dx.doi.org/10.1016/j.jcf.2016.10.009